DRIPTANE 5mg tablets medication leaflet

G04BD04 oxybutynin • Genito urinary system and sex hormones | Urologicals | Drugs for urinary frequency and incontinence

Oxybutynin is a medication used to treat overactive bladder and other urinary disorders associated with detrusor instability. It belongs to the class of anticholinergics and works by relaxing the bladder muscles, thereby reducing involuntary contractions and the frequency of urinary urgency.

It is indicated for relieving symptoms such as frequent urination, urinary incontinence, and the urgent need to urinate. Oxybutynin is available in tablet form, transdermal patches, or oral solutions, with the dosage adjusted based on the patient's needs.

Common side effects include dry mouth, constipation, drowsiness, dizziness, and blurred vision. In rare cases, confusion or allergic reactions may occur. It is important to take oxybutynin as prescribed by a healthcare provider, and patients with glaucoma, gastrointestinal obstructions, or other conditions should inform their doctor before use.

DRIPTANE 5mg tablets MYLAN, oxybutynin

General data about DRIPTANE 5mg

Substance: oxybutynin

Date of last drug list: 01-05-2026

Commercial code: W62337001

Concentration: 5mg

Pharmaceutical form: tablets

Quantity: 60

Product type: generic

Price: 28.02 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: RECIPHARM FONTAINE - FRANTA

Holder: MYLAN MEDICAL S.A.S. - FRANTA

Number: 9945/2017/01

Shelf life: 3 years

Pharmaceutical forms available for oxybutynin

Concentrations available for oxybutynin

3.9mg/24h, 5mg

Compensation lists for DRIPTANE 5mg Mylan

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

28.02 RON

8.66 RON

19.36 RON